Company Profile
Updated: 28-OCT-09Sandoz Industrial Products S.A.
Non-Quoted Public Company
Ctra Granoller-Cardedeu Km 4.3, Les Franqueses del Valles, E-08520, Spain
()34 93 840 44 00, 34 93 840 44 01 fax, http://www.novartis.es
Primary SIC: Medical Chemicals & Botanical Products, Primary NAICS: Medicinal and Botanical Manufacturing
Description: Manufacturing: Manufacture of semi-synthetic antibiotics. During 2000 the Company was world leader in the production of semi-synthetic penicillins; pharmaceutical research
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Emisphere Technologies Appoints Tim Rothwell to the Board of Directors.
Biotech Week; 11/18/2009; 960 words; ...to bring our first product - oral Eligen[R...Sanofi-aventis U.S. From September 2004...as coordination of Industrial Affairs and Research...Sanofi-aventis U.S. in 2004. Prior...President of the company's Global Prescription...Executive Officer of Sandoz Pharmaceuticals...
Research and Markets Adds: Ukraine Pharmaceuticals and Healthcare Report Q4 2009.(Report)
Health & Beauty Close-Up; 10/29/2009; 1055 words; ...appeal to voters in the industrial and Russophone eastern...The prime minister's penchant for interventionism...Control of Medicinal Products, a once moribund...Meanwhile, the country's public healthcare...Indar, the country's highest profile domestic...Lek (Novartis/Sandoz) Report ...
NVS, URS, OKE, RVBD, MESA, APU Expected To Be Higher Leading Up To Next Earnings Releases.
M2 Presswire; 10/6/2009; 3362 words; ...to the market's perception of the...marketing of healthcare products worldwide. Its...The companyas Sandoz division offers...Plc; Euroscreen S.A.; and Nuevolution A/S. The company was...Federal, and industrial and commercial market...
Reportlinker Adds Global Generics Report.
Business Wire; 10/6/2009; 1569 words; ...OTC generics 3.5 Top 20 products in the US 3.6 Major generic...Convention for the Protection of Industrial Property (PCPIP) 9.4...Strategies 10.1.4 Outlook 10.2 Sandoz 10.2.1 Business profile...Outlook 10.10 Dr. Reddy's Laboratories Ltd. 10.10...
Research and Markets: Opportunities For Biosimilars Market Is Immense, As Biologics Worth US$25 Billion Are Going To Be Off-Patent By 2016.
Business Wire; 9/25/2009; 1492 words; ...2014 after the U.S. market opens up...Biocon, Dr. Reddy's Lab, Intas, LG...Reliance LifeSciences, Sandoz, Teva, and Wockhardt...market on the basis of products, services, technology...applications. Biosimilars product market Peptides...and the market's cash cows (BCG ...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
